Timothy E. Albertson, M.D., M.P.H., Ph.D. for UC Davis Health

Timothy E. Albertson, M.D., M.P.H., Ph.D.

Chair, Department of Internal Medicine

Professor, Department of Internal Medicine

To see if Timothy E. Albertson is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Reviews

Specialties

Pulmonary and Critical Care

Pharmacology

Emergency Medicine

Anesthesiology

Toxicology

Pain Medicine

Locations and Contact

UC Davis Medical Group - Sacramento (J Street)

Pulmonary, Critical Care and Sleep Medicine
2825 J St.
Sacramento, CA 95816

Get Directions

Additional Numbers

Clinic Fax

916-734-7969

Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

I believe in caring for patients and their families with respect, dignity and compassion. I focus on communicating effectively with my patients, being sensitive to their overall needs and concerns as well as their immediate medical problem. I keep my patients informed, answer their questions frankly, and involve them and their families in any decision-making process.

At UC Davis Health, my patients can benefit from the highest level of care achievable because of our state-of-the-art resources, knowledge, skills and technology. As a long-time resident of the Sacramento area, I have established good relationships with many health-care professionals, and I enjoy working with our community physicians and other hospitals, sharing knowledge and expertise to provide quality patient

Clinical Interests

Dr. Albertson is a leading expert in Clinical Pharmacology and Toxicology, Aeromedicine, and Septic and Adult Respiratory Distress Syndrome.

Research/Academic Interests

Dr. Albertson's research and academic interests include: Sepsis, ARDS, Toxicology, Clinical research in IPF and Covid research.

Division

Pulmonary, Critical Care, and Sleep Medicine
Emergency Medicine
General Anesthesiology

Center/Program Affiliation

UC Davis Medical Group

Undergraduate School

B.A., Biology and Physiology, UC San Diego, San Diego CA 1973

Medical School

M.D., UC Davis School of Medicine, Sacramento CA 1977

Other School

M.S.S., U.S. Army War College, 2003

Other School

M.P.H., UC Berkeley School of Public Health, Berkeley CA 2003

Other School

M.S., Pharmacology and Toxicology, UC Davis, Davis CA 1976

Other School

Ph.D., Pharmacology and Toxicology, UC Davis, Davis CA 1980

Internship

Internal Medicine, University of Arizona, Tucson AZ 1977-1978

Residency

Internal Medicine, Critical Care Emergency Medicine, UC Davis, Davis CA 1980-1981

Residency

Internal Medicine, University of Arizona, Tucson AZ 1979-1980

Fellowship

Pulmonary and Critical Care Disease, UC Davis, Davis CA 1981-1983

Fellowship

Pharmacology, UC Davis, Davis CA 1978-1979

Best Doctors in America List selected by a nationwide peer-review poll of physicians, 2017, 2018, 2019, 2020, 2021

Sacramento Magazine's Top Doctors List for Critical Care Medicine, Pulmonary Disease and Emergency Medicine, 2016, 2017, 2018, 2019, 2020, 2021

Distinguished Professor, 2019

United States Pharmacopoeia (USP) Award for an Outstanding Contribution to USP Standards: Healthcare Quality and Safety Expert Committee, 2016

Awarded the Order of California - California Military Department. The Order of California is the third highest award in the State’s pyramid of honor, and is the highest award for exceptionally meritorious service, 2016

To see a full list of Dr. Albertson's publications, please click here.

Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Van Dromme I, Spiessens B, Vingerhoets J, Custers J, Scheper G, Robb ML, Treanor J, Ryser MF, Barouch DH, Swann E, Marovich MA, Neuzil KM, Corey L, Stoddard J, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S. N Engl J Med. 2022 Mar 3;386(9):847-860. doi:10.1056/NEJMoa2117608. Epub 2022 Feb 9. PMID:35139271.

I-SPY COVID Consortium. Clinical trial design during and beyond the pandemic: the I-SPY COVID trial. Nat Med. 2022 Jan;28(1):9-11. doi:10.1038/s41591-021-01617-x. PMID:35058620.

Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Trial Investigators. REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. N Engl J Med. 2021 Dec 2;385(23):e81. doi:10.1056/NEJMoa2108163.

Mir T, Uddin M, Qureshi WT, Abohashem S, Alqalyoobi S, Sheikh M, Soubani A, Saydain G, Albertson TE. ST-Elevation Myocardial Infarction Among Septic Shock and Coronary Interventions: A National Emergency Database Study. J Intensive Care Med. 2021 Nov 23:8850666211061731. doi:10.1177/08850666211061731. Epub ahead of print. PMID:34812084.

Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med. 2021 Nov 4;385(19): 1761-1773. doi:10.1056/NEJMoa2110345.

Friedman AN, Guirguis J, Kapoor R, Gupta S, Leaf DE, Timsina LR; STOP-COVID Investigators. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021 Oct;29(10):1719-1730. doi:10.1002/oby.23245. Epub 2021 Aug 6. PMID:34109768.

Molinari L, Heskia F, Peerapornratana S, Ronco C, Guzzi L, Toback S, Birch R, Beyhaghi H, Kwan T, Kampf JP, Yealy DM, Kellum JA; Sapphire and Protocolized Care for Early Septic Shock (ProCESS) Investigators. Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation. Crit Care Med. 2021 Oct 1;49(10):1706-1716. doi:10.1097/CCM.0000000000005061. PMID:33927121.

Lewis JC, Lim M, Lai L, Mendoza E, Albertson TE, Chenoweth JA. Evaluation of N-acetylcysteine dose for the treatment of massive acetaminophen ingestion. Clin Toxicol (Phila). 2021 Sep 28:1-7. doi:10.1080/15563650.2021.1984503. Epub ahead of print. PMID:34581655.